ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Bin Sun
Matched on ORCID iD 0000-0002-5663-4294; OpenAlex author ID A5006007746. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 6
- CSF1-CAR Specifically Targets CSF1R + Pancreatic Cancer Cells and Tumor-Associated Macrophages. Last author DOI 10.1097/cji.0000000000000563↗
- GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. Co-author DOI 10.1186/s13045-023-01467-9↗
- PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5. Co-author DOI 10.1007/s13577-020-00463-2↗
- Smad4 deficiency substitutes Cdkn2b but not Cdkn2a downregulation in pancreatic cancer following induction of genetic events in adult mice. First author DOI 10.1016/j.pan.2021.01.004↗
- Anticancer effect of SZC015 on pancreatic cancer via mitochondria-dependent apoptosis and the constitutive suppression of activated nuclear factor κB and STAT3… Co-author DOI 10.1002/jcp.26892↗
- CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A. Co-author DOI 10.1038/onc.2017.316↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiawei Fan · 2 shared papers, 2023–2025 · strength 0.51
- Xudong Zhao · 3 shared papers, 2018–2023 · strength 0.37
- Paper GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer. DOI 10.1186/s13045-023-01467-9↗
- Paper Smad4 deficiency substitutes Cdkn2b but not Cdkn2a downregulation in pancreatic cancer following induction of genetic e… DOI 10.1016/j.pan.2021.01.004↗
- Paper CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition… DOI 10.1038/onc.2017.316↗
- Yongjie Zhu · 1 shared paper, 2025 · strength 0.33
- Qiu Tu · 2 shared papers, 2018–2021 · strength 0.19
- Paper Smad4 deficiency substitutes Cdkn2b but not Cdkn2a downregulation in pancreatic cancer following induction of genetic e… DOI 10.1016/j.pan.2021.01.004↗
- Paper CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition… DOI 10.1038/onc.2017.316↗
- Yuncang Yuan · 1 shared paper, 2023 · strength 0.18
- Xiongxiong Lu · 1 shared paper, 2021 · strength 0.14
- Jing Xie · 1 shared paper, 2021 · strength 0.14
- Haitao Chen · 1 shared paper, 2021 · strength 0.14
- Xintong Jia · 1 shared paper, 2021 · strength 0.12
- Yanlin Song · 1 shared paper, 2018 · strength 0.07
- Peng Chu · 1 shared paper, 2018 · strength 0.07
- Jinyong Peng · 1 shared paper, 2018 · strength 0.07
- Zeyao Tang · 1 shared paper, 2018 · strength 0.07
- Ren Lai · 1 shared paper, 2018 · strength 0.07
- Dejun Yang · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.